SANOFI (SNW.DE) Stock Fundamental Analysis
Europe - FRA:SNW - FR0000120578 - Common Stock
79.66 EUR
-1.27 (-1.57%)
Overall SNW gets a fundamental rating of 6 out of 10. We evaluated SNW against 49 industry peers in the Pharmaceuticals industry. SNW scores excellent on profitability, but there are some minor concerns on its financial health. SNW has a correct valuation and a medium growth rate. SNW also has an excellent dividend rating. With these ratings, SNW could be worth investigating further for dividend investing!.
1. Profitability
1.1 Basic Checks
SNW had positive earnings in the past year.
SNW had a positive operating cash flow in the past year.
In the past 5 years SNW has always been profitable.
SNW had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
SNW's Return On Assets of 11.05% is fine compared to the rest of the industry. SNW outperforms 77.55% of its industry peers.
With a decent Return On Equity value of 19.73%, SNW is doing good in the industry, outperforming 67.35% of the companies in the same industry.
SNW's Return On Invested Capital of 13.84% is fine compared to the rest of the industry. SNW outperforms 69.39% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SNW is significantly below the industry average of 15.25%.
The 3 year average ROIC (7.31%) for SNW is below the current ROIC(13.84%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROIC | 13.84% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
SNW's Profit Margin of 20.35% is fine compared to the rest of the industry. SNW outperforms 77.55% of its industry peers.
SNW's Profit Margin has improved in the last couple of years.
SNW's Operating Margin of 23.59% is in line compared to the rest of the industry. SNW outperforms 59.18% of its industry peers.
In the last couple of years the Operating Margin of SNW has grown nicely.
With a Gross Margin value of 71.70%, SNW perfoms like the industry average, outperforming 53.06% of the companies in the same industry.
In the last couple of years the Gross Margin of SNW has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SNW is creating value.
Compared to 1 year ago, SNW has about the same amount of shares outstanding.
The number of shares outstanding for SNW remains at a similar level compared to 5 years ago.
Compared to 1 year ago, SNW has an improved debt to assets ratio.
2.2 Solvency
SNW has a debt to FCF ratio of 2.21. This is a good value and a sign of high solvency as SNW would need 2.21 years to pay back of all of its debts.
SNW has a better Debt to FCF ratio (2.21) than 79.59% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that SNW is not too dependend on debt financing.
SNW's Debt to Equity ratio of 0.21 is fine compared to the rest of the industry. SNW outperforms 69.39% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Altman-Z | N/A |
ROIC/WACC1.86
WACC7.44%
2.3 Liquidity
SNW has a Current Ratio of 1.27. This is a normal value and indicates that SNW is financially healthy and should not expect problems in meeting its short term obligations.
SNW has a Current ratio (1.27) which is in line with its industry peers.
SNW has a Quick Ratio of 1.27. This is a bad value and indicates that SNW is not financially healthy enough and could expect problems in meeting its short term obligations.
SNW's Quick ratio of 0.94 is in line compared to the rest of the industry. SNW outperforms 46.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
The earnings per share for SNW have decreased by -2.20% in the last year.
Measured over the past 5 years, SNW shows a small growth in Earnings Per Share. The EPS has been growing by 5.10% on average per year.
Looking at the last year, SNW shows a small growth in Revenue. The Revenue has grown by 6.45% in the last year.
SNW shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.31% yearly.
EPS 1Y (TTM)-2.2%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%-8.09%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-6.99%
3.2 Future
SNW is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.41% yearly.
Based on estimates for the next years, SNW will show a small growth in Revenue. The Revenue will grow by 4.04% on average per year.
EPS Next Y3.91%
EPS Next 2Y6.53%
EPS Next 3Y6.33%
EPS Next 5Y6.41%
Revenue Next Year-0.29%
Revenue Next 2Y3.32%
Revenue Next 3Y4.42%
Revenue Next 5Y4.04%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 10.55 indicates a reasonable valuation of SNW.
Based on the Price/Earnings ratio, SNW is valued a bit cheaper than 79.59% of the companies in the same industry.
SNW is valuated cheaply when we compare the Price/Earnings ratio to 27.27, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 9.14, which indicates a very decent valuation of SNW.
Based on the Price/Forward Earnings ratio, SNW is valued a bit cheaper than the industry average as 77.55% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of SNW to the average of the S&P500 Index (22.77), we can say SNW is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.55 | ||
| Fwd PE | 9.14 |
4.2 Price Multiples
SNW's Enterprise Value to EBITDA ratio is in line with the industry average.
SNW's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.29 | ||
| EV/EBITDA | 10.26 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SNW does not grow enough to justify the current Price/Earnings ratio.
SNW has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.7
PEG (5Y)2.07
EPS Next 2Y6.53%
EPS Next 3Y6.33%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.86%, SNW is a good candidate for dividend investing.
SNW's Dividend Yield is rather good when compared to the industry average which is at 3.04. SNW pays more dividend than 83.67% of the companies in the same industry.
SNW's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.86% |
5.2 History
The dividend of SNW has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
SNW pays out 34.82% of its income as dividend. This is a sustainable payout ratio.
SNW's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.82%
EPS Next 2Y6.53%
EPS Next 3Y6.33%
FRA:SNW (9/15/2025, 7:00:00 PM)
79.66
-1.27 (-1.57%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners40.34%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap194.29B
Analysts80
Price Target110.07 (38.17%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.86% |
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)1.23%
PT rev (3m)-5.05%
EPS NQ rev (1m)-2.88%
EPS NQ rev (3m)-10.87%
EPS NY rev (1m)-4.12%
EPS NY rev (3m)-4.12%
Revenue NQ rev (1m)-0.28%
Revenue NQ rev (3m)-6.9%
Revenue NY rev (1m)-1.28%
Revenue NY rev (3m)-1.8%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.55 | ||
| Fwd PE | 9.14 | ||
| P/S | 2.86 | ||
| P/FCF | 19.29 | ||
| P/OCF | 17.07 | ||
| P/B | 2.78 | ||
| P/tB | 20.9 | ||
| EV/EBITDA | 10.26 |
EPS(TTM)7.55
EY9.48%
EPS(NY)8.72
Fwd EY10.94%
FCF(TTM)4.13
FCFY5.18%
OCF(TTM)4.67
OCFY5.86%
SpS27.84
BVpS28.7
TBVpS3.81
PEG (NY)2.7
PEG (5Y)2.07
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROCE | 16.7% | ||
| ROIC | 13.84% | ||
| ROICexc | 16.48% | ||
| ROICexgc | 66.95% | ||
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% | ||
| FCFM | 14.83% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexcg growth 3Y-13.63%
ROICexcg growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Debt/EBITDA | 0.75 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 58.05% | ||
| Profit Quality | 72.91% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | N/A |
F-Score7
WACC7.44%
ROIC/WACC1.86
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.2%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%-8.09%
EPS Next Y3.91%
EPS Next 2Y6.53%
EPS Next 3Y6.33%
EPS Next 5Y6.41%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-6.99%
Revenue Next Year-0.29%
Revenue Next 2Y3.32%
Revenue Next 3Y4.42%
Revenue Next 5Y4.04%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year34.08%
EBIT Next 3Y14.6%
EBIT Next 5Y9.88%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%